Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The risk of ...
Both complete and incomplete vaccination in individuals were associated with a significantly lower detection rate of high-risk HPV 16/18 and 16/18/31/33/45 in CIN2 compared with no vaccination.
Introduction Self-sampling for cervical cancer screening is a promising strategy to improve coverage and reduce strain on ...
Twenty years on since the approval of the first human papillomavirus (HPV) vaccine, a raft of studies involving millions of people have reached the same conclusion: HPV vaccination is safe and ...
Twenty-four patients with human papillomavirus (HPV)-associated cervical intraepithelial neoplasia (CIN); of whom 13 had CIN 1, 8 had CIN 2, and 3 had CIN 3; were treated with recombinant alpha 2b ...
HealthDay News — Combining human papillomavirus (HPV) DNA testing with cytology testing at first screening resulted in fewer cases of high-grade cervical intraepithelial neoplasia (CIN) lesions and ...
HPV vaccination alongside surgical treatment for cervical lesions may reduce risk of further disease
Giving women the human papillomavirus (HPV) vaccine around the time they have surgery for precancerous cervical lesions might lead to a reduction in the risk of lesions returning as well as other ...
The Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I and II trials evaluated efficacy of the quadrivalent human papillomavirus (HPV) recombinant Gardasil. In the FUTURE II ...
A simple urine test for human papillomavirus (HPV) may be a more acceptable alternative to conventional screening methods that require a cervical smear, and could increase uptake in hard-to-reach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback